The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy.
Oktay Halit AktepeDeniz Can GuvenTaha Koray SahinHasan Cagri YildirimBurcu CeliktenHaci Hasan YeterDeniz YuceOmer DizdarMustafa ErmanPublished in: Nutrition and cancer (2021)
Our study revealed that high RDW level, a routinely and easily assessed marker, was significantly associated with worse survival outcomes in mRCC patients treated with targeted therapy.